{"DataElement":{"publicId":"10392289","version":"1","preferredName":"Patient Prior Registration Laboratory Procedure Eligibility Determination Type","preferredDefinition":"The type of laboratory procedure performed as part of the determination of the eligibility for enrollment in a study.","longName":"2778188v1.00:3236002v1.00","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"2778188","version":"1","preferredName":"Patient Prior Registration Laboratory Procedure Eligibility Determination","preferredDefinition":"information related to the medical procedure that involves testing a sample of blood, urine, or other substance from a person who receives medical attention, care, or treatment prior to the act of enrolling on a clinical trial as a determination of the suitable for enrollment in a study according specific protocol criteria and procedures.","longName":"PT_P_REG_LAB_ELIG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2778186","version":"1","preferredName":"Prior Registration Laboratory Procedure Eligibility Determination","preferredDefinition":"Earlier in time or order.:Registration; the act of enrolling.:A medical procedure that involves testing a sample of blood, urine, or other substance from the body. Tests can help determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time.:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C25629:C25646:C25294:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Registration","conceptCode":"C25646","definition":"The act of listing or recording officially; officially qualified or enrolled.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55726A7F-C1C1-12FC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-27","modifiedBy":"ONEDATA","dateModified":"2008-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55726A7F-C1D2-12FC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3236002","version":"1","preferredName":"Person Test Clinical Trial Eligibility Criteria Type","preferredDefinition":"a subdivision of the procedure for critical evaluation as an elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"3236002v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"SGOT (AST)","valueDescription":"SGOT (AST)","ValueMeaning":{"publicId":"2562566","version":"1","preferredName":"SGOT (AST)","longName":"2562566","preferredDefinition":"A family of pyridoxal phosphate-dependent enzymes involved in amino acid metabolism and in the urea and tricarboxylic acid cycles. Aspartate aminotransferase specifically and reversibly catalyzes the transfer of an amino group from L-aspartate to alpha-ketoglutarate forming oxaloacetate and L-glutamate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aspartate Aminotransferase","conceptCode":"C25202","definition":"A family of pyridoxal phosphate-dependent enzymes involved in amino acid metabolism and in the urea and tricarboxylic acid cycles. Aspartate aminotransferase specifically and reversibly catalyzes the transfer of an amino group from L-aspartate to alpha-ketoglutarate forming oxaloacetate and L-glutamate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C173-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-04","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-04","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3A72C57-325A-B6D7-E040-BB89AD4367F9","beginDate":"2011-05-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-05-19","modifiedBy":"ONEDATA","dateModified":"2011-05-19","deletedIndicator":"No"},{"value":"Alkaline Phosphatase","valueDescription":"Alkaline Phosphatase","ValueMeaning":{"publicId":"2570082","version":"1","preferredName":"Alkaline Phosphatase","longName":"2570082","preferredDefinition":"Alkaline Phosphatase","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DECF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3A72C57-3265-B6D7-E040-BB89AD4367F9","beginDate":"2011-05-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-05-19","modifiedBy":"ONEDATA","dateModified":"2011-05-19","deletedIndicator":"No"},{"value":"Both Alkaline Phosphatase and SGOT (AST)","valueDescription":"Both Alkaline Phosphatase and SGOT (AST)","ValueMeaning":{"publicId":"3263464","version":"1","preferredName":"Both Alkaline Phosphatase and SGOT (AST)","longName":"3263464","preferredDefinition":"Both Alkaline Phosphatase and SGOT (AST)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AADCEB6E-8B8C-55C0-E040-BB89AD431D97","latestVersionIndicator":"Yes","beginDate":"2011-08-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AADCEB6E-8BA5-55C0-E040-BB89AD431D97","beginDate":"2011-08-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-08-19","modifiedBy":"ONEDATA","dateModified":"2011-08-19","deletedIndicator":"No"},{"value":"Creatinine clearance","valueDescription":"Creatinine clearance","ValueMeaning":{"publicId":"3630168","version":"1","preferredName":"Creatinine clearance","longName":"3630168","preferredDefinition":"Creatinine clearance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF6C4760-67F9-DEB3-E040-BB89AD434AC4","latestVersionIndicator":"Yes","beginDate":"2012-11-26","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-11-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF6C4760-6812-DEB3-E040-BB89AD434AC4","beginDate":"2012-11-26","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-11-26","modifiedBy":"ONEDATA","dateModified":"2012-11-26","deletedIndicator":"No"},{"value":"Creatinine","valueDescription":"Creatinine","ValueMeaning":{"publicId":"2570204","version":"1","preferredName":"Creatinine","longName":"2570204","preferredDefinition":"Creatinine","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF49-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF6C4760-681C-DEB3-E040-BB89AD434AC4","beginDate":"2012-11-26","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-11-26","modifiedBy":"ONEDATA","dateModified":"2012-11-26","deletedIndicator":"No"},{"value":"Urine protein","valueDescription":"Urine protein","ValueMeaning":{"publicId":"3623637","version":"1","preferredName":"Urine protein","longName":"3623637","preferredDefinition":"Urine protein","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCC0508E-0B52-CCE3-E040-BB89AD433AA5","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CCC0508E-0B6B-CCE3-E040-BB89AD433AA5","beginDate":"2012-10-23","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","deletedIndicator":"No"},{"value":"UPC ratio","valueDescription":"UPC ratio","ValueMeaning":{"publicId":"3623638","version":"1","preferredName":"UPC ratio","longName":"3623638","preferredDefinition":"UPC ratio","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCC0508E-0B75-CCE3-E040-BB89AD433AA5","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CCC0508E-0B8E-CCE3-E040-BB89AD433AA5","beginDate":"2012-10-23","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-10-23","modifiedBy":"ONEDATA","dateModified":"2012-10-23","deletedIndicator":"No"},{"value":"SGPT (ALT)","valueDescription":"SGPT (ALT)","ValueMeaning":{"publicId":"3462303","version":"1","preferredName":"SGPT (ALT)","longName":"3462303","preferredDefinition":"A family of pyridoxal phosphate-dependent enzymes involved in cellular nitrogen metabolism, amino acid metabolism, and liver gluconeogenesis. Alanine aminotransferase specifically and reversibly catalyzes the transfer of an amino group from L-alanine to alpha-ketoglutarate forming pyruvate and L-glutamate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alanine Aminotransferase","conceptCode":"C25293","definition":"A family of pyridoxal phosphate-dependent enzymes involved in cellular nitrogen metabolism, amino acid metabolism, and liver gluconeogenesis. Alanine aminotransferase specifically and reversibly catalyzes the transfer of an amino group from L-alanine to alpha-ketoglutarate forming pyruvate and L-glutamate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0B56B41-DBF4-0B7D-E040-BB89AD4306C9","latestVersionIndicator":"Yes","beginDate":"2012-05-23","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-05-23","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0B56B41-DC0D-0B7D-E040-BB89AD4306C9","beginDate":"2012-05-23","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-05-23","modifiedBy":"ONEDATA","dateModified":"2012-05-23","deletedIndicator":"No"},{"value":"Both SGOT (AST) and SGPT (ALT)","valueDescription":"SGOT (AST) SGPT (ALT)","ValueMeaning":{"publicId":"3478238","version":"1","preferredName":"SGOT (AST) SGPT (ALT)","longName":"3478238","preferredDefinition":"Activity measured as a test of liver function, 46/47-kDa homodimeric human Aspartate Aminotransferases (Class-I Pyridoxal-Phosphate-Dependent Aminotransferase Family) are pyridoxal phosphate-dependent enzymes involved in amino acid metabolism and in the urea and tricarboxylic acid cycles. (NCI): Activity measured as a test of liver function, human Glutamic-Pyruvate Transaminases (Alanine Aminotransferase Family) are pyridoxal phosphate-dependent enzymes involved in cellular nitrogen metabolism, amino acid metabolism, and liver gluconeogenesis. Glutamic Pyruvic Transaminases mediate conversion of major intermediate metabolites, catalyzing reversible transamination between alanine and alpha-ketoglutarate to form pyruvate and glutamate. (NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aspartate Aminotransferase","conceptCode":"C25202","definition":"A family of pyridoxal phosphate-dependent enzymes involved in amino acid metabolism and in the urea and tricarboxylic acid cycles. Aspartate aminotransferase specifically and reversibly catalyzes the transfer of an amino group from L-aspartate to alpha-ketoglutarate forming oxaloacetate and L-glutamate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Alanine Aminotransferase","conceptCode":"C25293","definition":"A family of pyridoxal phosphate-dependent enzymes involved in cellular nitrogen metabolism, amino acid metabolism, and liver gluconeogenesis. Alanine aminotransferase specifically and reversibly catalyzes the transfer of an amino group from L-alanine to alpha-ketoglutarate forming pyruvate and L-glutamate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C251EB5B-9C78-D33E-E040-BB89AD435A18","latestVersionIndicator":"Yes","beginDate":"2012-06-12","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-06-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C251EB5B-9C91-D33E-E040-BB89AD435A18","beginDate":"2012-06-12","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2012-06-12","modifiedBy":"ONEDATA","dateModified":"2012-06-12","deletedIndicator":"No"},{"value":"Both Creatinine and Creatinine Clearance","valueDescription":"Both Creatinine And Creatinine Clearance","ValueMeaning":{"publicId":"6117738","version":"1","preferredName":"Both Creatinine And Creatinine Clearance","longName":"6117738","preferredDefinition":"One and the other; relating to or being two in conjunction.: The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The determination of the clearance of endogenous creatinine, used for evaluating the glomerular filtration rate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Both","conceptCode":"C49636","definition":"One and the other; relating to or being two in conjunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Creatinine","conceptCode":"C399","definition":"The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Creatinine Clearance","conceptCode":"C25747","definition":"The determination of the clearance of endogenous creatinine, used for evaluating the glomerular filtration rate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66D7BEA4-AD5F-0259-E053-F662850ACCF5","latestVersionIndicator":"Yes","beginDate":"2018-03-08","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-03-08","modifiedBy":"ONEDATA","dateModified":"2018-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66D7BEA4-AD78-0259-E053-F662850ACCF5","beginDate":"2018-03-08","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-03-08","modifiedBy":"ONEDATA","dateModified":"2018-03-08","deletedIndicator":"No"},{"value":"Both Urine protein and UPC ratio","valueDescription":"Both Urine Protein Measurement And Urine Protein to Creatinine Ratio Measurement","ValueMeaning":{"publicId":"6847982","version":"1","preferredName":"Both Urine Protein Measurement And Urine Protein to Creatinine Ratio Measurement","longName":"6847982","preferredDefinition":"One and the other; relating to or being two in conjunction.: The determination of the amount of protein present in a urine sample.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The fluid that is excreted by the kidneys.  It is stored in the bladder and discharged through the urethra.: The determination of the ratio of total protein compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Both","conceptCode":"C49636","definition":"One and the other; relating to or being two in conjunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Urine Protein Measurement","conceptCode":"C74760","definition":"The determination of the amount of protein present in a urine sample.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Urine","conceptCode":"C13283","definition":"The fluid that is excreted by the kidneys.  It is stored in the bladder and discharged through the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Protein to Creatinine Ratio Measurement","conceptCode":"C79463","definition":"The determination of the ratio of total protein compared to creatinine present in a sample. The measurement may be expressed as a ratio or percentage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F88ACCE-B6F5-7413-E053-F662850A9BBD","latestVersionIndicator":"Yes","beginDate":"2019-08-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-07","modifiedBy":"ONEDATA","dateModified":"2019-08-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F88ACCE-B70E-7413-E053-F662850A9BBD","beginDate":"2019-08-07","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-07","modifiedBy":"ONEDATA","dateModified":"2019-08-07","deletedIndicator":"No"},{"value":"Both International Normalized Ratio (INR) And  Prothrombin Time (PT)","valueDescription":"Both International Normalized Ratio And Prothrombin Time","ValueMeaning":{"publicId":"6941886","version":"1","preferredName":"Both International Normalized Ratio And Prothrombin Time","longName":"6941886","preferredDefinition":"One and the other; relating to or being two in conjunction.: A system, commonly called the INR, established by the World Health Organization (WHO) and the International Committee on Thrombosis and Hemostasis for reporting the results of blood coagulation (clotting) tests. All results are standardized using the international sensitivity index (ISI) for the particular thromboplastin reagent and instrument combination utilized to perform the test; the ratio of a patient's clotting time to the lab's mean reference value is normalized against the ISI. (from medterms.com and medicine.ucsf.edu): An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Both","conceptCode":"C49636","definition":"One and the other; relating to or being two in conjunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"International Normalized Ratio","conceptCode":"C25352","definition":"A system, commonly called the INR, established by the World Health Organization (WHO) and the International Committee on Thrombosis and Hemostasis for reporting the results of blood coagulation (clotting) tests. All results are standardized using the international sensitivity index (ISI) for the particular thromboplastin reagent and instrument combination utilized to perform the test; the ratio of a patient's clotting time to the lab's mean reference value is normalized against the ISI. (from medterms.com and medicine.ucsf.edu)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prothrombin Time","conceptCode":"C62656","definition":"A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"92D0F347-D75B-48B8-E053-F662850ABA4F","latestVersionIndicator":"Yes","beginDate":"2019-09-18","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-09-18","modifiedBy":"ONEDATA","dateModified":"2019-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92D0F347-D774-48B8-E053-F662850ABA4F","beginDate":"2019-09-18","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-09-18","modifiedBy":"ONEDATA","dateModified":"2019-09-18","deletedIndicator":"No"},{"value":"International Normalized Ratio (INR)","valueDescription":"International Normalized Ratio","ValueMeaning":{"publicId":"2833109","version":"1","preferredName":"International Normalized Ratio","longName":"2833109","preferredDefinition":"System established by the World Health Organization and the International Committee on Thrombosis and Hemostasis for monitoring and reporting blood coagulation tests. Under this system, results are standardized using the International Sensitivity Index for the particular test reagent/instrument combination used.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Normalized Ratio","conceptCode":"C25352","definition":"A system, commonly called the INR, established by the World Health Organization (WHO) and the International Committee on Thrombosis and Hemostasis for reporting the results of blood coagulation (clotting) tests. All results are standardized using the international sensitivity index (ISI) for the particular thromboplastin reagent and instrument combination utilized to perform the test; the ratio of a patient's clotting time to the lab's mean reference value is normalized against the ISI. (from medterms.com and medicine.ucsf.edu)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"621D07D9-0388-271C-E040-BB89AD43153D","latestVersionIndicator":"Yes","beginDate":"2009-02-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92D0F347-D788-48B8-E053-F662850ABA4F","beginDate":"2019-09-18","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-09-18","modifiedBy":"ONEDATA","dateModified":"2019-09-18","deletedIndicator":"No"},{"value":"Prothrombin Time (PT)","valueDescription":"Prothrombin Time","ValueMeaning":{"publicId":"2833108","version":"1","preferredName":"Prothrombin Time","longName":"2833108","preferredDefinition":"A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prothrombin Time","conceptCode":"C62656","definition":"A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"621D07D9-0365-271C-E040-BB89AD43153D","latestVersionIndicator":"Yes","beginDate":"2009-02-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-04","modifiedBy":"KUMMEROA","dateModified":"2023-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"92D0F347-D79D-48B8-E053-F662850ABA4F","beginDate":"2019-09-18","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-09-18","modifiedBy":"ONEDATA","dateModified":"2019-09-18","deletedIndicator":"No"},{"value":"Both Creatinine and Calculated Creatinine Clearance","valueDescription":"Both Creatinine and Calculated Creatinine Clearance","ValueMeaning":{"publicId":"7050415","version":"1","preferredName":"Both Creatinine and Calculated Creatinine Clearance","longName":"7050415","preferredDefinition":"Both Creatinine and Calculated Creatinine Clearance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97299C00-5890-424D-E053-F662850A03FE","latestVersionIndicator":"Yes","beginDate":"2019-11-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-11-12","modifiedBy":"ONEDATA","dateModified":"2019-11-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97299C00-58A9-424D-E053-F662850A03FE","beginDate":"2019-11-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-11-12","modifiedBy":"ONEDATA","dateModified":"2019-11-12","deletedIndicator":"No"},{"value":"Calculated Creatinine Clearance","valueDescription":"Calculation Creatinine Clearance","ValueMeaning":{"publicId":"7050416","version":"1","preferredName":"Calculation Creatinine Clearance","longName":"7050416","preferredDefinition":"The procedure or activity of determining something by mathematical or logical methods.: The determination of the clearance of endogenous creatinine, used for evaluating the glomerular filtration rate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Calculation","conceptCode":"C54125","definition":"The procedure or activity of determining something by mathematical or logical methods.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Creatinine Clearance","conceptCode":"C25747","definition":"The determination of the clearance of endogenous creatinine, used for evaluating the glomerular filtration rate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97299C00-58B6-424D-E053-F662850A03FE","latestVersionIndicator":"Yes","beginDate":"2019-11-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-11-12","modifiedBy":"ONEDATA","dateModified":"2019-11-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97299C00-58CF-424D-E053-F662850A03FE","beginDate":"2019-11-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-11-12","modifiedBy":"ONEDATA","dateModified":"2019-11-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ACOSOG CRF:American College of Surgeons Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3A72C57-3244-B6D7-E040-BB89AD4367F9","latestVersionIndicator":"Yes","beginDate":"2011-05-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-05-19","modifiedBy":"CAMPBELB","dateModified":"2019-11-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Which test was completed for eligibility?","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-A3F1-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-05-31","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-05-31","modifiedBy":"ZHWENDY","dateModified":"2023-01-20","changeDescription":null,"administrativeNotes":"1/20/2023: created per CADSR0001935.wz","unresolvedIssues":null,"deletedIndicator":"No"}}